Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,CSU Case Studies Whats New

    Updates to Chronic Spontaneous Urticaria
    Knowledge Centre

    The Chronic Spontaneous Urticaria (CSU) Knowledge Centre has been
    updated with two new slide decks from CSU experts discussing real-life patient
    scenarios. The case studies explore how treatment recommendations in the
    recent best-practice guidelines can be applied in the dermatology clinic.

  • ,Hyperammonaemia Knowledge Centre

    Launch of Hyperammonaemia Knowledge Centre

    Could you recognise the signs and symptoms of hyperammonaemia?
    Healthcare professionals have FREE access to a new educational resource providing up
    to date disease awareness information, treatment options, video channel and resources
    to help them quickly identify and treat this potentially life-threatening condition.

  • ,Bedwetting Knowledge Centre What's New

    Launch of the Updated Bedwetting
    Knowledge Centre

    The Bedwetting Knowledge Centre has been given a fresh new look with a
    mobile-responsive design. Users will be better able to use their mobile devices
    to explore sections on disease awareness, publication summaries and a case
    study-led CME activity with ease. Ensure you return to visit this resource often
    to avoid missing out on a number of upcoming content updates.

  • ,What's New Thrombosis Educational Portal

    Thrombosis Educational Portal (Advertorial)

    Containing sections on thrombosis, venous thromboembolism (VTE) prevention and
    treatment, atrial fibrillation, acute coronary syndrome (ACS) and quarterly-updated
    newsletters, the Thrombosis Educational Portal provides healthcare professionals
    with links to a comprehensive resource used in the treatment and management
    of venous and arterial thrombosis.

  • ,

    Launch of ‘IL-17A in Psoriasis’ section

    Located within the Psoriasis Knowledge Centre is a new IL-17A in Psoriasis
    educational area. This resource has been developed primarily to discuss the role
    of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential
    of treatments directed towards IL-17A. Users will find expert videos, clinical
    presentations on topics such as disease perception and emerging therapies, congress
    highlights, key publications and useful resources.

    This resource has been developed in collaboration with Novartis Pharma AG.

Latest News

Positive results in phase III trial of BA 058 (abaloparatide subcutaneous) in patients with postmenopausal osteoporosis- Radius Health


Radius Health has announced positive top-line data from the Phase III ACTIVE trial, which showed that women with postmenopausal osteoporosis (PMO) who received 18 months of daily BA 058 (abaloparatide subcutaneous or ABL-SC) injection experienced a ...

Positive outcomes from phase II trial of Cirara (glibenclamide for injection) in stroke patients- Remedy Pharmaceuticals


Remedy Pharmaceuticals announced preliminary results from GAMES-RP, an exploratory Phase II randomized double blind, placebo-controlled, multi-center trial in severe stroke patients administered Cirara (glibenclamide for injection). The 90-day follow ...

Five year study of Lap-Band device for obesity published in International Journal of Obesity- Apollo Endosurgery


A five-year pivotal study, published in the International Journal of Obesity, tracked the health outcomes for 149 LAP-BAND patients from six US states with a BMI of 30 to 39.9. Results showed that 76% of patients achieved and sustained at least 30% ...

Case studies added to Chronic Spontaneous Urticaria (CSU) Knowledge Centre


​ Two slide decks from leading dermatology experts have been added to the Chronic Spontaneous Urticaria (CSU) Knowledge Centre. These are: Bringing the urticaria guidelines to life – Elias Toubi A 44-year-old female presents with ...

FDA approves extension of Opdivo (nivolumab) to include metastatic NSCLC where disease has progressed after platinum chemotherapy- BMS


The FDA has approved Opdivo (nivolumab), from BMS, to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy. The safety and effectiveness of nivolumab for this use ...

FDA accepts filing of sNDA to provide for single dose Dalvance (dalbavancin) for ABSSSI (skin infections)- Allergan


Allergan has announced that the FDA has accepted for filing Allergan's supplemental New Drug Application (sNDA) to expand the label to include single-dose administration of Dalvance (dalbavancin) for the treatment of acute bacterial skin and skin ...

Phase III extension study shows Cosentyx (secukinumab) efficacy in plaque psoriasis- Novartis


New data demonstrates that Cosentyx (secukinumab), from Novartis, provides high levels of skin clearance and sustained efficacy in patients with moderate-to-severe plaque psoriasis while maintaining a favourable safety profile across three years. ...

Recent Updates


Clinical Guidelines

Management of Obesity in Adults: European Clinical Practice Guidelines

British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia

Guidelines on the measurement of ultraviolet radiation levels in ultraviolet phototherapy: report issued by the British Association of Dermatologists and British Photodermatology Group 2015

Coeliac disease: recognition, assessment and management

Medical Journals

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis.

Predictors of Excess Weight Loss in Obese Patients After Gastric Bypass: a 60-Month Follow-up.

Virtual Reality-Enhanced Cognitive-Behavioral Therapy for Morbid Obesity: A Randomized Controlled Study with 1 Year Follow-Up.

Associations between poor sleep quality and different measures of obesity.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors